Skip to main content
Clinical Trials/JPRN-jRCTs031200359
JPRN-jRCTs031200359
Recruiting
Phase 2

Effect of intensified multifactorial intervention on coronary atherosclerosis in patients with coronary artery disease and type 2 diabetes (IMPACT-DM): an open-label, randomized controlled trial - IMPACT-DM

Hibi Kiyoshi0 sites312 target enrollmentFebruary 12, 2021

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
Hibi Kiyoshi
Enrollment
312
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 12, 2021
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Hibi Kiyoshi

Eligibility Criteria

Inclusion Criteria

  • Patients with coronary artery disease and diabetes mellitus who underwent sucessful PCI in the target lesions and had significant coronary plaques in non\-target leisons

Exclusion Criteria

  • Patients with bypass graft, in\-stent restenosis, lesions with previous PCI treatments, lesions with severe calcification, familial hypercholesterolemia, type 1 diabetes mellitus, insulin treatment, history of operation of gastrointestinal tracts, severe renal and/or liver dysfunction, severe cardiac dysfunction, cancer treatments, cerebrovascular disease within 3 months before the enrollment, treatments of infectious diseases or any operation within 3 months after the enrollment, treatments with immunosuppressants and prednisolone, active bleeding, allergy and/or adverse events to stduy drugs, asthma, or pregnant or lactating women

Outcomes

Primary Outcomes

Not specified

Similar Trials